Gentibio

Cambridge · Founded 2020 · $177.0M raised

Headquarters
Cambridge
Employees
51–200
Founded
2020
Business Model
B2B
Total Funding
$177.0M
Last Round
$157.0M Series AAug 2021
Rounds
2

About

GentiBio is a clinical-stage biotechnology company developing engineered regulatory T-cell (Treg) therapies to treat Type 1 diabetes and other autoimmune and acute inflammatory diseases. The company's modular engineering platform creates optimized Tregs with immune-evasive properties for both autologous and allogeneic approaches, advancing multiple programs through clinical trials toward potential cures.

Summary

Gentibio is a Biotech company based in Cambridge, founded in 2020. It has raised $177.0M in total across 2 rounds, most recently a $157.0M Series A round in Aug 2021. Investors include OrbiMed, Matrix Capital Management and Avidity Partners.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series ASeries AAug 2021
$157.0M

Sign up to see all 2 rounds

Seed through Series A — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Gentibio on Indexed.vc
<a href="https://indexed.vc/companies/gentibio"><img src="https://indexed.vc/api/badge/company/gentibio" alt="Gentibio on Indexed.vc" width="260" height="76" /></a>